Home-Based SolUtion for Remote Atrial Fibrillation Screening to PrevenT RecUrrence StrOke (HUA-TUO AF Trial)

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1740 participants.

Also called NCT04523649

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose screening
Phase
Not applicable
Enrolled
  • 1,740 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04523649
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04523649. Randomized; single masking; primary purpose screening. Start 2022-06-01 (anticipated); primary completion 2024-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Home-Based SolUtion for Remote Atrial Fibrillation Screening to PrevenT RecUrrence StrOke (HUA-TUO AF Trial)
Acronym
HUA-TUO
Condition
Stroke, Cardiovascular
Intervention (Device)
Remote atrial fibrillation screening with handheld single lead ECG (electrocardiogram) recorder
Lead sponsor
The University of Hong Kong (class: other)

Record details

Record id
cardio:ct-nct04523649
Content hash
fccdde5ef5ea38c81263a00cd0e7a98b6c62e0601ff675b3015d0fe982e099c7